Sublingual semaglutide offered to UK practices despite Novo Nordisk concerns
An unlicensed semaglutide-based product that is administered under the tongue is being marketed to private doctors in the…
iDexis taking legal advice after court rules against it in weight-loss jab case
Compounding pharmacy iDexis says it is taking legal advice after the high court ordered it to stop producing…
Novo Nordisk Expands GLP-1 Reach With Oral Ozempic And Pediatric Push
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…
Novo Nordisk takes legal action against Hims & Hers to protect patients from unsafe, … | National
Hims & Hers unlawfully mass markets unapproved versions of Novo Nordisk’s FDA-approved semaglutide medicines, deceiving patients and putting…
Novo Nordisk takes legal action against Hims & Hers to
Hims & Hers unlawfully mass markets unapproved versions of Novo Nordisk’s FDA-approved semaglutide medicines, deceiving patients and putting…
Novo Nordisk issues statement on illegal mass compounding and deceptive advertising by Hims & Hers
Novo Nordisk A/S Bagsværd, Denmark and Plainsboro, NJ, 5 February 2026 – Novo Nordisk today issued the following…
Novo Nordisk issues statement on illegal mass compounding and deceptive advertising by Hims & Hers
Novo Nordisk A/S Bagsværd, Denmark and Plainsboro, NJ, 5 February 2026 – Novo Nordisk today issued the following…
Novo Nordisk Confronts Hims Over Wegovy Pill Copies And GLP 1 Future
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…